OBI1 and hepatocellular carcinoma: Consistently, compared with control mice, the RNF219‐silenced HCC cells‐injected mice exhibited delayed bone metastases, reduced BM lesions/osteolytic areas, less BMD reduction, and fewer SREs frequency (Figure S2A–G and Table S6, Supporting Information).